- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT06566664
Peripheral Neurostimulation
Peripheral nerve blocks are routinely used and highly successful for intra-operative anesthesia and post-operative pain management. Nerve blocks are guided using either neurostimulation as a means to localize the right nerve or by ultrasound guidance or combining the 2 methods. The purpose of this study is to assess whether electrical stimulation improves nerve block quality, beyond its simple purpose of nerve localization.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
The investigators wish to understand how electrical stimulation can affect local anesthetic disposition when performing a peripheral nerve block.
By studying this subject, the investigators open possibilities for improvement on many levels:
increasing the efficacy of the nerve block allows for a reduced onset time, reduced incidence of incomplete block, and prolonged duration of the local anesthetics. This allows for patients to fully benefit from the analgesic properties of the nerve block, allows for a decrease in delays for the operating room readiness, and a allows for a decrease in the amount of medication needed for a successful nerve block. This will decrease side effects and risks of the nerve blocks. Overall better post-surgical pain control may decrease risks for developing chronic post-operative pain, a major post-operative complication.
The results of this study will open the door to novel approaches to manage acute post-operative pain.
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
California
-
Stanford, California, États-Unis, 94305
- Stanford University Hospital
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Undergoing elective upper limb surgery with a planned brachial plexus nerve block
Exclusion Criteria:
- Under 18 years old
- ASA score above III
- Chronic pain condition with daily milligrams of morphine equivalent > 30
- Poorly controlled psychiatric condition
- Coagulopathy
- Active infection
- Moderate, severe or progressing neuropathy
- COPD/Chronic oxygen user
- Pregnancy
- Incarceration
- Unable to consent
- BMI > 35
- Pacemaker
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Double
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Ultrasound-guided brachial plexus block with peripheral nerve stimulation
Patients will receive a brachial plexus catheter with ultrasound guidance as per standard of care, with additional use of the B. Braun HNS 12 nerve stimulator during the loading dose of local anesthesia to maintain a gentle twitch. |
Nerve stimulator that is traditionally used for nerve localization during block placements. |
|
Comparateur factice: Ultrasound-guided brachial plexus block without peripheral nerve stimulation
Patients will receive the brachial plexus catheter in the same way the first arm would, and the B Braun nerve stimulator will be placed in the same way, but the ground electrode will not be connected to the patient. |
Stimulator will be placed and turned on, but the grounding electrode will not be connected to prevent nerve stimulation. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Onset of Motor Block
Délai: Within 1 hour after the block placement.
|
Determining time when patient experiences first symptoms of local anesthetic action on the upper trunk distribution (median or musculo cutaneous nerve) |
Within 1 hour after the block placement.
|
|
Onset of Sensory Block
Délai: Within 1 hour after the block placement.
|
Determining time when patient experiences first symptoms of local anesthetic action on the superior trunk distribution over the shoulder. |
Within 1 hour after the block placement.
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Skin Temperature Change
Délai: Immediately before and up to 1 hour after neurostimulation and nerve block is performed.
|
Measuring changes in skin temperature over the course of pre and post stimulation and nerve blocking between the blocked and unblocked arms, measured in degrees Celsius. Using Medline Temperature Sensor. |
Immediately before and up to 1 hour after neurostimulation and nerve block is performed.
|
|
When Patient Experiences First Pain
Délai: up to day 7 post operatively
|
Time after surgery at which the patient experiences first sign of pain at the surgical site, as measured by the time for first local anesthetic bolus based on pump device history. |
up to day 7 post operatively
|
|
Time of First Opioid Taken
Délai: Within the first 7 days after surgery
|
As measured by asking patients if they were taking opioids daily after surgery, up to one week. |
Within the first 7 days after surgery
|
|
Total Post Operative MME/Opioid Usage at Day 1
Délai: On Post Operative Day 1
|
Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg). |
On Post Operative Day 1
|
|
Total Post Operative MME/Opioid Usage at Day 2
Délai: On Post Operative Day 2
|
Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg). |
On Post Operative Day 2
|
|
Total Post Operative MME Opioid Usage at Day 3
Délai: On Post Operative Day 3
|
Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg). |
On Post Operative Day 3
|
|
Total Post Operative MME Opioid Usage at Day 4
Délai: On Post Operative Day 4
|
Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg). |
On Post Operative Day 4
|
|
Total Post Operative MME Opioid Usage at Day 5
Délai: On Post Operative Day 5
|
Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg). |
On Post Operative Day 5
|
|
Total Post Operative MME Opioid Usage at Day 6
Délai: On Post Operative Day 6
|
Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg). |
On Post Operative Day 6
|
|
Opioid Usage Assessment at Day 7
Délai: On Post Operative Day 7
|
Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg). |
On Post Operative Day 7
|
|
Opioid Usage Assessment at Day 28
Délai: On Post Operative Day 28
|
Milligram of morphine equivalent, measured by asking patients 1) if patients took opioids within the last 3 weeks and 2) if so, how many pills per day. |
On Post Operative Day 28
|
|
Opioid Usage Assessment at 6 Months
Délai: On Post Operative Month 6
|
Milligram of morphine equivalent, measured by asking patients 1) if patients took opioids within the last 5 months and 2) if so, how many pills per day. |
On Post Operative Month 6
|
|
Opioid Usage Assessment at 1 Year
Délai: On Post Operative 1 Year
|
Milligram of morphine equivalent, measured by asking patients 1) if patients took opioids within the last 6 months and 2) if so, how many pills per day. |
On Post Operative 1 Year
|
|
Quality of Recovery
Délai: At Post Operative days 7 and 28 , 6 months, and 1 year
|
Using the standardized -Quality of Recovery 15- at post operative days 7 and 28, 6 months, and 1 year. Each item count on a 0-10 scale where 0 is worst and 10 is best. PART A How have you been feeling in the last 24 hours? (0 to 10, where 0 = none of the time [poor] and 10 = all of the time [excellent]) Q.1 Able to breathe easily Q.2 Been able to enjoy food Q.3 Feeling rested Q.4 Have had a good sleep Q.5 Able to look after personal toilet and hygiene unaided Q.6 Able to communicate with family or friends Q.7 Getting support from hospital doctors and nurses Q.8 Able to return to work or usual home activities Q.9 Feeling comfortable and in control Q.10 Having a feeling of general well-being PART B Have you had any of the following in the last 24 hours? (10 to 0, where 10 = none of the time [excellent] and 0 = all of the time [poor]) Q.11 Moderate pain Q.12 Severe pain Q.13 Nausea or vomiting Q.14 Feeling worried or anxious Q.15 Feeling sad or depressed |
At Post Operative days 7 and 28 , 6 months, and 1 year
|
|
General satisfaction
Délai: At post operative days 0, 1, 7, 28, 6 months, and 1 year
|
General satisfaction on a scale from 1-5 (extremely unsatisfied, unsatisfied, neutral, satisfy, extremely satisfied). Asking patients if they would receive the block again (Y/N). |
At post operative days 0, 1, 7, 28, 6 months, and 1 year
|
|
Adverse Events
Délai: Asked to patients (Check all that apply) at Post Operative Day 0, 1, 7, 28, 6 Months, and 1 Year. Patients have the opportunity to specify in detail for each sympom they select.
|
Numbness, Weakness, Tingling, Breathing Difficulties, Hoarseness |
Asked to patients (Check all that apply) at Post Operative Day 0, 1, 7, 28, 6 Months, and 1 Year. Patients have the opportunity to specify in detail for each sympom they select.
|
|
Catheter Duration Before Discontinuation
Délai: After surgery, up until catheter discontinuation.
|
Patients' catheter duration before discontinuation, as measured by Avoset pump device data. |
After surgery, up until catheter discontinuation.
|
|
Total Local Anesthetic Use with Catheter
Délai: After surgery, up until catheter discontinuation.
|
Patients' local anesthetic use with catheter, as measured by Avoset pump device data. |
After surgery, up until catheter discontinuation.
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 76523
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
produit fabriqué et exporté des États-Unis.
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .